The increasing importance of globalization has made representation in international arenas more important. Yet key factors affecting associability of business and public interest groups at that level are markedly different from those which apply at the level of the nation-state. This article will argue that the “privileged position of business” does not obtain at the transnational level, and that business frequently prefers the national route. ngos, on the other hand, enjoy greater influence international than they do at the national level, essentially because of the ways in which they can assist international organizations to overcome their governance deficits. Examining sectors such as chemicals and biotechnology, this article explores the factors affecting associability at the international level and suggests some consequences which follow from these observations for the development of policy in international arenas.
Braithwaite, J. and P. Drahos (2000). Global Business Regulation. Cambridge: Cambridge University Press.
2.
Carson, R. (1962). Silent Spring. Boston: Houghton Mifflin.
3.
Clow, S. (1992). The International Nickel Trade. Cambridge: Woodhead Publishing.
4.
Comaner, W. S. (1986). “The Political Economy of the Pharmaceutical Industry.”Journal of Economic Literature, 24: 178-217.
5.
Davis, L. N (1984). The Corporate Alchemists: The Power and Problems of the Chemical Industry. London: Temple Smith.
6.
de Ghellinck, E. (1992). “The Chemical and Pharmaceutical Industries” In The European Challenge (D.G. Mayes, ed.). London: Harvester Wheatsheaf.
7.
gen (2000) at http://www/dmac.co/uk/gen.html, accessed 6 April, 2000.
8.
gentech Archive (2000) at http:11www.dmac.co.uk/gen.html, accessed 6 April, 2000.
9.
Grant, W. , W. Paterson, and C. Whitston (1989). Government and the Chemical Industry: A Comparative Study of Britain and West Germany. Oxford: Clarendon Press.
10.
Haber, L. F. (1971). The Chemical Industry 1900-1930. Oxford: Oxford University Press.
11.
Hanf, K. and A. Underdal (1998). “Domesticating International Commitments: Linking National and International Decision-Making.” In The Politics of International Environmental Management (A. Underdal, ed.). Dordrecht: Kluwer.
12.
Harrison, R. J. and S. Mungall (1978). “Harmonization.” In International Organization: A Conceptual Approach (P. Taylor and A. J. R. Groom, eds.). London: Frances Pinter.
13.
Henderson, D. (1999). “The mai Affair: A Story and its Lessons,” (Pelham Paper No. 5). Melbourne: Melbourne Business School.
14.
Hufbauer, G. C. (1966). Synthetic Materials and the Theory of International Trade. London: Duckworth.
15.
Kellow, A. (1999). International Toxic Risk Management: Ideals, Interests and Implementation. Cambridge: Cambridge University Press.
16.
Kellow, A. (2000). “Norms, Interests and Environment ngos: The Limits of Cosmopolitanism.”Environmental Politics, 9: 1-22.
17.
Kilbourne, E. M. , R. M. Philen, M.L. Kamb, and H. Falk (1996). “Tryptophan produced by Showa Denko and epidemic eosinophilia-myalgia syndrome.”Rheumatol Suppl, 46: 81-88.
18.
Korten, D. (1996). When Corporations Rule the World. London: Earthscan.
19.
Krasner, S. D. (1995). “Power politics, institutions and transnational relations.” In Bringing Transnational Relations Back In: Non-State Actors, Domestic Structures and International Institutions (Thomas Risse-Kappen ed.). Cambridge: Cambridge University Press.
20.
Levy, D. L. and D. Egan (1998). “Capital Contests: National and Transnational Channels of Corporate Influence on the Climate Change Negotiations.”Politics and Society, 26: 337-361.
21.
Lindblom, C. E. (1977). Politics and Markets. New York: Basic Books.
22.
Losey, J. E., L. S. Rayor , and M. E. Carter (1999). “Transgenic pollen harms monarch butterfly.”Nature, 199: 214.
23.
Mayeno, A.N. and G. J. Gleich (1994), “Eosinophilia-myalgia syndrome and tryptophan production: a cautionary tale.”Trends Biotechnol, 12(9): 346-352.
24.
Monsanto Monitor (2000) at http://antenna.nl/aseed/monsanto/, accessed 6 April, 2000.
25.
Nichols, J. K. and P. J. Crawford (1983). Managing Chemicals in the 1980s. Paris, oecd.
26.
pga (2000) at http//www.agp/index.html, accessed 6 April, 2000.
27.
Philen, R. M. , R. H. Hill, Jr., W. D. Flanders, S. P. Caudill, L. Needham, L. Sewell, E. J. Sampson, H. Falk, and E.M. Kilbourn (1993). “Tryptophan contaminants associated with eosinophilia-myalgia syndrome: The Eosinophilia-Myalgia Studies of Oregon, New York and New Mexico,”Am J Epidemiol., 138(3): 154-160
28.
Princen, T. and M. Finger (1994). Environmental ngos in World Politics: Linking the Local and the_Global. London: Routledge.
29.
Rueben, B. G. and M. L. Burstall (1973). The Chemical Economy. London: Longman.
30.
Sandbrook, R , (1997). “ungass Has Run Out of Steam.”International Affairs, 73: 641-654.
31.
Schweitzer, G. E. (1991). Borrowed Earth, Borrowed Time: Healing America's Chemical Wounds. New York: Plenum Press.
32.
Tolba, M. K. and O. A. El-Kholy (1992). The World Environment 1972-1992: Two Decades of Challenge. London: Chapman and Hall/unep.
33.
Varga, J. , J. Uitto, and S. A. Jimenez (1992). “The cause and pathogenesis of the eosinophilia-myalgia syndrome.”Ann. Intern. Med., 116(2): 1407.
34.
Vogel, D. (1995). Trading Up: Consumer and Environmental Regulation in a Global Economy. Cambridge, ma: Harvard University Press.
35.
Willetts, P. (1982). “The impact of promotional pressure groups on global politics.” In Pressure Groups in the Global System: The Transnational Relations of Issue-Oriented Non-Governmental Organizations (Peter Willetts ed.). London: Frances Pinter.
36.
Willetts, P. (1996). “From Stockholm to Rio and Beyond: The Impact of the Environmental Movement on the United Nations Consultative Arrangements for ngos.”Review of International Studies, 22: 57-80.
